Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Possible Involvement of Nitrergic and Opioidergic Systems in the Modulatory Effect of Acute Chloroquine Treatment on Pentylenetetrazol Induced Convulsions in Mice Publisher Pubmed



Hassanipour M1, 2, 3 ; Shirzadian A1, 2 ; Boojar MMA1, 2 ; Abkhoo A1, 2 ; Abkhoo A1, 2 ; Delazar S1, 2 ; Amiri S1, 2 ; Rahimi N1, 2 ; Ostadhadi S1, 2, 4 ; Dehpour AR1, 2, 4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Experimental Medicine Research Center, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Pharmacology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Department of Physiology and Pharmacology, School of Medicine, Rafsanjan University of Medical Sciences, Kerman, Iran
  4. 4. Brain and Spinal Cord Injury Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran

Source: Brain Research Bulletin Published:2016


Abstract

Chloroquine has long been used for the treatment of malaria and rheumatological disorders. Accumulating evidence suggests potential use of chloroquine as a neuroprotective agent. Several studies have reported that endogenous opioids and nitric oxide (NO) system mediate the chloroquine effects. In the present study, the involvements of endogenous opioids and NO in the modulatory effects of chloroquine on pentylenetetrazol-induced seizures were assessed in mice. Chloroquine 5 mg/kg significantly increased the seizure threshold, but this effect was reversed with naltrexone 1 mg/kg. Acute co-administration of l-NAME (non-selective NO synthase (NOS) inhibitor, 5 mg/kg) or 7-NI (selective neuronal NOS inhibitor, 40 mg/kg) with the effective dose of chloroquine completely inhibited its anticonvulsant effects. Acute single injection of a sub-effective dose of l-arginine (NO precursor, 60 mg/kg) with a sub-effective dose of chloroquine 2.5 mg/kg increased the seizure threshold but administration of l-arginine 60 mg/kg with chloroquine 10 mg/kg decreased the seizure threshold. Moreover, the combination of the lower doses of naltrexone (0.1 mg/kg) and 7-NI (15 mg/kg) showed additive effects in blocking the chloroquine-induced anticonvulsant properties. Chloroquine 5 mg/kg enhanced the hippocampal nitrite levels. Chloroquine at the dose of 20 mg/kg decreased the seizure threshold. This effect was inhibited through l-NAME (5 mg/kg), 7-NI (40 mg/kg) and naltrexone (1 mg/kg) administration with this dose of chloroquine. In conclusion, NO signaling probably through neuronal NOS, but not inducible NOS could be involved in the opioid-dependent anticonvulsant effects of chloroquine in this model of seizures in mice. It seems that nitric oxide and opioid systems are involved in modulatory effect of chloroquine on seizures induced by pentylenetetrazol. © 2016 Published by Elsevier Inc.
Other Related Docs